Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.36124 | 53 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.30911 | 53 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.30079 | 53 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.2143 | 52 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.28694 | 54 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.67145 | 60 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.41786 | 54 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.41074 | 56 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.25904 | 52 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.28661 | 53 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.29463 | 53 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.24079 | 52 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.31109 | 53 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.30217 | 53 |